Get notified when SILO files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: SILO Silo Pharma, Inc. 8-K

Silo Pharma completes 1-for-15 reverse stock split to boost share price

Filed June 3, 2026 · Period ending June 1, 2026 · ~1 min read

Key Changes

  • high

    Reverse stock split became effective June 2, 2026 at 4:01 p.m. ET, with every 15 shares combined into 1 share. Split-adjusted trading began June 3 on Nasdaq under ticker SILO with new CUSIP 82711P 300.

    Item 5.03: Reverse Stock Split verify on EDGAR →
  • medium

    Authorized shares reduced proportionately to 6,666,667 shares while par value remains $0.0001 per share, maintaining the same ratio of authorized to outstanding shares as before the split.

    Item 5.03: Authorized Shares verify on EDGAR →
  • medium

    All outstanding stock options, warrants, and equity plan reserves adjusted proportionately—exercise prices increased 15x while share counts decreased by factor of 15, preserving economic value for holders.

    Item 5.03: Equity Awards verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade SILO commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify